TOKYO, January 31, 2025--Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive Officer (CEO), effective April 1 ...
We sat down with Haran Maheson, Vice President & Head of Oncology at Daiichi Sankyo UK, to find out more about the company’s rapid growth, their vision to transform cancer care in the UK ...
and Daiichi Sankyo Co Ltd, a pharmaceutical firm, over IHH’s open offer for the 26% of shares in Fortis Healthcare Ltd that the company does not own may not see a definitive outcome anytime soon ...
It's the end of the road for the South San Francisco-based company, which became part of the Daiichi Sankyo in a $935 million deal in 2011 and since then has contributed two approved cancer ...
J.P. Morgan analyst Seiji Wakao maintained a Hold rating on PHC Holdings Corp. (2GY – Research Report) yesterday and set a price target of ...
there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website ...
Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...
1d
TipRanks on MSNDai-ichi Life Holdings to Rebrand as Daiichi Life GroupDai-ichi Life Holdings ( ($JP:8750) ) has issued an update. Dai-ichi Life Holdings announced that it will change its trade ...
The company has one out-licensed asset (zanidatamab), for which sponsor Jazz Pharmaceuticals recently received its first of what it hopes are many oncology indication approvals. Zymeworks also has ...
At close: February 13 at 3:00:00 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results